FDA Decision Watch: MRK, MIRM, INCY, GRAL Face Key Regulatory Catalysts This Week

Merck, Mirum, Incyte and Grail are in focus this week as investors await key FDA decisions and a regulatory review involving treatments for lung disease, a rare bone disorder and cancer detection.